# ARGOS THERAPEUTICS INC

ARGOS THERAPEUTICS INC is a company headquartered in Durham, NC, United States.

## Company overview

- **Legal name:** ARGOS THERAPEUTICS INC
- **Former names in filing history:** MERIX BIOSCIENCE INC (2004-03-01 to 2004-10-12)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Durham, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001105533

## About

ARGOS THERAPEUTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001105533, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-04-02, it reported annual revenue of USD 1,899,398; net income of USD -40,577,510; total assets of USD 20,777,764 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $1.9M (USD 1,899,398)
- **Net income:** -$40.6M (USD -40,577,510)
- **Total assets:** $20.8M (USD 20,777,764)
- **Cash and equivalents:** $15.2M (USD 15,188,838)
- **Operating cash flow:** -$35.4M (USD -35,424,886)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $945,468 (USD 945,468)
- **Net income:** -$53.0M (USD -53,028,110)
- **Total assets:** $97.2M (USD 97,204,391)
- **Cash and equivalents:** $53.0M (USD 52,973,376)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $518,329 (USD 518,329)
- **Net income:** -$74.8M (USD -74,788,521)
- **Total assets:** $31.1M (USD 31,131,202)
- **Cash and equivalents:** $6.2M (USD 6,163,144)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $2.0M (USD 1,974,019)
- **Net income:** -$53.3M (USD -53,305,938)
- **Total assets:** $64.4M (USD 64,366,878)
- **Cash and equivalents:** $37.2M (USD 37,223,590)

## Recent SEC filings

- Form 8-K — filed 2019-05-03 — period 2019-05-01 — FORM 8-K
- Form 8-K — filed 2018-12-03 — period 2018-11-29 — FORM 8-K
- Form 10-Q — filed 2018-11-19 — period 2018-09-30 — FORM 10-Q
- Form 10-Q — filed 2018-08-20 — period 2018-06-30 — FORM 10-Q
- Form 8-K — filed 2018-07-20 — period 2018-07-16 — FORM 8-K
- Form 10-Q — filed 2018-05-15 — period 2018-03-31 — FORM 10-Q
- Form 8-K — filed 2018-04-24 — period 2018-04-19 — FORM 8-K
- Form 8-K — filed 2018-04-19 — period 2018-04-19 — FORM 8-K
- Form 10-K — filed 2018-04-02 — period 2017-12-31 — FORM 10-K
- Form 8-K — filed 2018-04-02 — period 2018-04-02 — FORM 8-K
- Form 8-K — filed 2018-03-07 — period 2018-03-07 — FORM 8-K
- Form 8-K — filed 2018-02-16 — period 2018-02-15 — FORM 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/argos-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology